PubRank
Search
About
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
Clinical Trial ID NCT00775281
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00775281
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis.
Br J Urol
1997
1.85
2
Increased number of substance P positive nerve fibres in interstitial cystitis.
Br J Urol
1995
1.39
3
Bladder surface glycosaminoglycans is a human epithelial permeability barrier.
Surg Gynecol Obstet
1990
1.25
4
The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
J Urol
2001
1.19
5
Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis.
J Urol
1992
1.03
6
Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis.
Br J Urol
1998
1.01
7
Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis.
J Urol
1994
0.99
8
Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis.
Am J Pathol
2000
0.97
9
Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis.
Br J Urol
1996
0.89
10
Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis.
Urology
1996
0.84
Next 100